Clozapine-related obsessive-compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study.

Katherine Parkin ORCID logo; Shanquan Chen ORCID logo; Marjan Biria ORCID logo; James Plaistow ORCID logo; Helen Beckwith ORCID logo; Isaac Jarratt-Barnham ORCID logo; Nuria Segarra ORCID logo; Yulia Worbe ORCID logo; Naomi A Fineberg ORCID logo; Rudolf N Cardinal ORCID logo; +2 more... Trevor W Robbins ORCID logo; Emilio Fernandez-Egea ORCID logo; (2022) Clozapine-related obsessive-compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study. Psychological medicine. pp. 1-10. ISSN 0033-2917 DOI: 10.1017/S003329172100492X
Copy

BACKGROUND: Obsessive-compulsive symptoms (OCS) are commonly associated with clozapine treatment but are frequently overlooked by clinicians despite their potential impact on patients' quality of life. In this study, we explored whether OCS severity impacted subjective wellbeing and general functioning, independently of depressive and psychotic symptoms. METHODS: We used anonymised electronic healthcare records from a large cohort of patients who were treated with clozapine and assessed annually for OCS, wellbeing, general functioning, and psychopathology using standardised scales as part of routine clinical practice. We used statistical mixed linear model techniques to evaluate the longitudinal influence of OCS severity on wellbeing and general functioning. RESULTS: A total of 184 patients were included, with 527 face-to-face assessments and 64.7% evaluated three or more times. Different linear mixed models demonstrated that OCS in patients treated with clozapine were associated with significantly worse wellbeing scores, independently of depression and psychotic symptoms, but OCS did not impair general functioning. Obsessional thinking and hoarding behaviour, but not compulsions, were significantly associated with the impact on wellbeing, which may be attributable to the ego-syntonic nature of the compulsions. CONCLUSIONS: Given the frequent occurrence of OCS and their negative impact on wellbeing, we encourage clinicians to routinely assess and treat OCS in patients who are taking clozapine.



picture_as_pdf
Parkin_etal_2022_Clozapine-related-obsessive-compulsive-symptoms.pdf
subject
Published Version
Available under Creative Commons: 4.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication: